🧪 Big step for #PrecisionOncology: the #IRBBarcelona–@icreacommunity.bsky.social spin-off #Inbiomotion sees its MAF Test® included in the SEOM–GEICAM–SOLTI guidelines as a clinically relevant tool for more personalised treatment decisions in early-stage #BreastCancer.

🔗 https://shorturl.at/a1IOW

🧪 Top Spanish hospitals adopt the MAF Test® to transform #BreastCancer care.
#IRBBarcelona + ICREA spin-off #Inbiomotion launches the test in selected hospitals in Barcelona & Madrid—marking a step forward in personalized treatment.

Video credits: Telenotícies 3Cat

#CancerResearch #Innovation

Top Spanish hospitals adopt the MAF Test, developed by @irbbarcelona.org #spinoff #InBioMotion, to improve #BreastCancer treatment

MAF helps determine which patients should be treated with bisphosphonates, improving prognosis & survival #BISTCommunity #PersonalisedMedicine

bist.eu/top-spanish-...

#PortfolioNews I MAF Test® now adopted in top #Spanish hospitals to personalize early-stage #breast #cancer treatment. A major step for our #portfolio company #Inbiomotion !

👉 Full details here - buff.ly/aT4nwud

#BreastCancer #Oncology #PortfolioNews #MAFTest

🧪Top Spanish hospitals adopt the MAF Test, by #IRBBarcelona spinoff #Inbiomotion, to improve breast cancer treatment. This test helps oncologists determine which #BreastCancer patients should be treated with bisphosphonates to improve their prognosis & survival.

➡️ shorturl.at/AbzSI

🎥 Credit: 3Cat

🧪Top Spanish hospitals adopt the MAF Test to improve breast cancer treatment. This pioneering test by #IRBBarcelona spinoff #Inbiomotion helps oncologists determine which #BreastCancer patients should be treated with bisphosphonates to improve their prognosis & survival.

➡️ https://shorturl.at/AbzSI